IP Verse

A Combination Of Oxycodone And Naloxone For Use In Treating Pain In Patients Suffering From Pain And A Disease Resulting In Intestinal Dysbiosis And/Or Increasing The Risk For Intestinal Bacterial Translocation

Patent No. EP3024461 (titled "A Combination Of Oxycodone And Naloxone For Use In Treating Pain In Patients Suffering From Pain And A Disease Resulting In Intestinal Dysbiosis And/Or Increasing The Risk For Intestinal Bacterial Translocation") was filed by Euro Celtique on Jul 23, 2014. The application was issued on May 13, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DEVELCO PHARMA SCHWEIZMay 14, 2020TER MEER STEINMEISTER & PARTNER
HEXAL PHARMAMay 14, 2020TER MEER STEINMEISTER & PARTNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3024461

EURO CELTIQUE
Application Number
EP14741915A
Filing Date
Jul 23, 2014
Status
Revoked
Oct 29, 2021
Publication Date
May 13, 2020
External Links
Slate, Register , Google Patents